We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
301
Pacira BioSciences
PCRX
$945M
$222K 0.02%
9,300
+18
+0.2% +$454
VEEV icon
302
Veeva Systems
VEEV
$39.2B
$222K 0.02%
771
– –
GRFS
303
Grifois
GRFS
$5.4B
$221K 0.02%
24,502
+32
+0.1% +$250
FLBL icon
304
Franklin Senior Loan ETF
FLBL
$858M
$218K 0.02%
+9,000
New +$215K
AMPH icon
305
Amphastar Pharmaceuticals
AMPH
$850M
$217K 0.02%
9,468
-176
-2% -$4.37K
DYN icon
306
Dyne Therapeutics
DYN
$4.89B
$217K 0.02%
22,829
+139
+0.6% +$1.53K
STZ icon
307
Constellation Brands
STZ
$22.9B
$214K 0.02%
1,314
-1,664
-56% -$298K
ABCL icon
308
AbCellera Biologics
ABCL
$3.18B
$206K 0.02%
59,949
+178
+0.3% +$443
NVAX icon
309
Novavax
NVAX
$1.31B
$205K 0.02%
32,531
+268
+0.8% +$1.77K
INSP icon
310
Inspire Medical Systems
INSP
$1.68B
$204K 0.02%
1,574
– –
CHA
311
Chagee Holdings Ltd
CHA
$1.91B
$204K 0.02%
+7,818
New +$240K
VERV
312
DELISTED
Verve Therapeutics
VERV
$201K 0.02%
17,904
+93
+0.5% +$530
ELVN icon
313
Enliven Therapeutics
ELVN
$4.24B
$198K 0.02%
9,855
+55
+0.6% +$1.04K
NTLA icon
314
Intellia Therapeutics
NTLA
$1.69B
$195K 0.02%
20,804
+40
+0.2% +$328
COLL icon
315
Collegium Pharmaceutical
COLL
$834M
$191K 0.02%
6,456
+141
+2% +$4.02K
ARDX icon
316
Ardelyx
ARDX
$1.03B
$188K 0.02%
48,053
+243
+0.5% +$1K
SPY icon
317
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$183K 0.02%
295
-131
-31% -$74.9K
SYRE icon
318
Spyre Therapeutics
SYRE
$9.18B
$181K 0.02%
12,122
+35
+0.3% +$518
GERN icon
319
Geron
GERN
$1.01B
$180K 0.02%
127,922
+170
+0.1% +$241
MLYS icon
320
Mineralys Therapeutics
MLYS
$2.38B
$177K 0.02%
13,090
+3,094
+31% +$44.8K
ZYME icon
321
Zymeworks
ZYME
$1.77B
$176K 0.02%
13,996
+180
+1% +$2.14K
NRIX icon
322
Nurix Therapeutics
NRIX
$2.76B
$174K 0.02%
15,312
+90
+0.6% +$973
PRAX icon
323
Praxis Precision Medicines
PRAX
$10.8B
$172K 0.02%
4,091
+47
+1% +$1.79K
AVDL
324
DELISTED
Avadel Pharmaceuticals
AVDL
$172K 0.02%
19,430
+102
+0.5% +$896
NTRA icon
325
Natera
NTRA
$45.5B
$169K 0.02%
+1,000
New +$156K
11 12
13
14 15

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.